Contents

SynopsisCodesLook ForDiagnostic PearlsDifferential Diagnosis & PitfallsBest TestsManagement PearlsTherapyReferences
Myoadenylate deaminase deficiency
Other Resources UpToDate PubMed

Myoadenylate deaminase deficiency

Contributors: Bo Hoon Lee MD, Richard L. Barbano MD, PhD
Other Resources UpToDate PubMed

Synopsis

Myoadenylate deaminase (mAMPD) deficiency is an autosomal recessive metabolic myopathy caused by mutations in the AMPD1 gene, which encodes mAMPD. This results in a defect in the ability to process the major energy molecule of the cell, adenosine triphosphate (ATP).

Patients most commonly present with exercise-induced myalgias and weakness. This can be associated with rhabdomyolysis in some patients. Infantile hypotonia has been described as well.

Of note, mAMPD deficiency is most commonly found in individuals of Northern European descent, and the estimated frequency of the most common mutant AMPD1 allele is 11%-14% among that population.

Codes

ICD10CM:
E79.2 – Myoadenylate deaminase deficiency

SNOMEDCT:
9105005 – Muscle adenosine monophosphate deaminase deficiency

Look For

Subscription Required

Diagnostic Pearls

Subscription Required

Differential Diagnosis & Pitfalls

To perform a comparison, select diagnoses from the classic differential

Subscription Required

Best Tests

Subscription Required

Management Pearls

Subscription Required

Therapy

Subscription Required

References

Subscription Required

Last Reviewed:09/10/2018
Last Updated:01/19/2022
Copyright © 2024 VisualDx®. All rights reserved.
Myoadenylate deaminase deficiency
Print  
A medical illustration showing key findings of Myoadenylate deaminase deficiency : Muscle weakness, Muscle cramp, Myalgia
Copyright © 2024 VisualDx®. All rights reserved.